Literature DB >> 15745491

Surgical exploration of the injured kidney: current indications and techniques.

Michael J Metro1, Jack W McAninch.   

Abstract

When treating renal injuries, the goals of the urologic surgeon are preservation of maximal renal function with a minimal risk of complications. To meet these, accurate staging is essential. The combined use of clinical and radiologic findings, with intra-operative information where available, will enhance the practitioner's ability to detect, classify, and treat renal injuries appropriately. We discuss our current approach to renal trauma and current indications and techniques for surgical exploration of the injured kidney.

Entities:  

Year:  2003        PMID: 15745491     DOI: 10.1590/s1677-55382003000200002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  3 in total

1.  Transperitoneal laparoscopic nephrectomy in acute Grade 4 renal trauma with literature review and a note on some unusual complications.

Authors:  Rohan Satish Valsangkar; Syed J Rizvi; Syed J F Quadri; Pranjal R Modi
Journal:  J Minim Access Surg       Date:  2017 Jul-Sep       Impact factor: 1.407

2.  Autologous omentum transposition for regeneration of a renal injury model in rats.

Authors:  Tayfun Bilgiç; Ümit İnce; Fehmi Narter
Journal:  Mil Med Res       Date:  2022-01-04

Review 3.  Kidney and uro-trauma: WSES-AAST guidelines.

Authors:  Federico Coccolini; Ernest E Moore; Yoram Kluger; Walter Biffl; Ari Leppaniemi; Yosuke Matsumura; Fernando Kim; Andrew B Peitzman; Gustavo P Fraga; Massimo Sartelli; Luca Ansaloni; Goran Augustin; Andrew Kirkpatrick; Fikri Abu-Zidan; Imitiaz Wani; Dieter Weber; Emmanouil Pikoulis; Martha Larrea; Catherine Arvieux; Vassil Manchev; Viktor Reva; Raul Coimbra; Vladimir Khokha; Alain Chichom Mefire; Carlos Ordonez; Massimo Chiarugi; Fernando Machado; Boris Sakakushev; Junichi Matsumoto; Ron Maier; Isidoro di Carlo; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-12-02       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.